Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma is a research paper published in Kidney Cancer (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5P50CA196516-05
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
National Institutes of Health
Grant: 5R21CA263264-02
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
Fields of Study
Keywords
Sustainable Development Goals